Jiangsu Hengrui Medicine (600276.SS) Financial Analysis & Valuation | Quarter Chart

Jiangsu Hengrui Medicine (600276.SS)

600276.SS
Price: $7.65
Fair Value: 🔒
🔒score
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-13... more
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, an... more
Description Shares
Market Cap$48.80BExchangeSHH
SectorHealthcareIndustryDrug Manufacturers - General
CountryCNCEOPiao Yang Sun
IPO Date2000-10-18CAGR0.18%
Employees20,238Websitewww.hrs.com.cn
Div. Yield0.48%Payout Ratio0.16%
Buy Back Yield0.36%Total Yield0.84%
600276.SS chart loading...
Fundamentals Technicals
Enterprise Value$325.37BP/E Ratio41.95
Forward P/E—PEG Ratio3.26
P/S Ratio8.27P/B Ratio4.38
P/CF Ratio24.23P/FCF Ratio31.56
EPS$0.18EPS Growth 1Y14.81%
EPS Growth 3Y103.28%EPS Growth 5Y22.77%
Revenue Growth 1Y11.55%Gross Margin0.86%
Operating Margin0.28%Profit Margin0.25%
ROE0.13%ROA0.11%
ROCE0.14%Current Ratio9.23
Quick Ratio8.72Cash Ratio7.19
Debt/Equity0Interest Coverage2315.17
Altman Z Score29.77Piotroski Score5

View Jiangsu Hengrui Medicine financial charts →